Articles for Nathan Geffen

Our justice system is grinding to a halt

Simple cases are taking years and years to be finalised

Investigation into social grant fraud is a flop

SASSA investigation into SRD grant application system fails to answer crucial questions

Elections 2024: Low voter turnout must be fixed

Glitches and slow queues need to be seen in light of IEC’s budget cuts

Thousands march in Cape Town in support of ICJ order against Israel

Case to stop Israeli attack on Rafah was brought by South African government

Google moves against notorious spam news website

BNN Breaking no longer appears high up in search results

Google and Facebook are killing local news

South Africans are living longer, mostly thanks to HIV treatment

Antiretroviral medicines have been a success, but more work is needed to reach United Nations targets

South African Jews call for ceasefire in Gaza

“We are a diverse group of South African Jews who are dismayed by the situation that is unfolding in Israel and Palestine”

Housing in South Africa: How have we done since 1994?

We’ve made progress but the quality of the data is poor, especially the latest census

March in Cape Town in support of Gaza as Israel orders evacuation

Official death toll rises to 3,000 - over 1,200 Israelis and about 1,800 Palestinians - as violence escalates

GroundUp reporters win prestigious journalism award

Marecia Damons and Daniel Steyn win 2023 Nat Nakasa Award for Thabo Bester prison escape story

How bad is South Africa’s murder rate?

And has the Western Cape turned the corner?

GroundUp told to remove Lottery article following fake copyright claim

If we don’t remove the article access to our website may be blocked

Why we investigated the Thabo Bester story

This was a story that was both immensely interesting and of immense public interest

DA leaders should follow Premier Winde’s example on vaccines

Inviting a British anti-vaxxer and sending mixed messages, especially during a measles outbreak, is endangering public health

New medicines for drug-resistant TB will save lives. But will they be affordable where they are most needed?

Study, published today in New England Journal Medicine, shows that a new regimen is safer and more effective than the current standard of care.